Journal: International journal of molecular sciences
Article Title: Vitamin A Promotes the Fusion of Autophagolysosomes and Prevents Excessive Inflammasome Activation in Dextran Sulfate Sodium-Induced Colitis.
doi: 10.3390/ijms24108684
Figure Lengend Snippet: Figure 4. Macrophages pretreated with RAR antagonist exhibit increased pyroptosis mediated via non-canonical inflammasome signaling. (a–m) Effect of RAR antagonist (Ro41-5253) on cell viability of murine macrophage cells (RAW 264.7) treated with LPS. RAW 264.7 cells were cultured in 10 mg/mL LPS for 24 h, pretreated with or without 10 mM Ro41-5253 for 1 h. Cell viability, cytotoxicity, cytokine production, and immunoblotting were examined at each time point. (a) Cell viability in the absence of LPS (n = 4), (b) cell viability in the presence of 10 mg/mL LPS (n = 4), (c) representative images of supernatants, and (d–g) morphology of RAW 264.7 cells upon Ro41-5253 and LPS treatment. (h,i) LDH was measured using Cytotox96 (non-radioactive cytotoxicity assay, Promega). (h) Cytotoxicity assay without LPS (n = 6) and (i) cytotoxicity assay in the presence of 10 mg/mL LPS (n = 6). (j–l) Titers of IL-1β, IL-18, and TNF-α in supernatants were measured using ELISA. (j) IL-1β production (n = 4), (k) IL-18 production (n = 4), (l) TNF-α production (n = 4), and (m) immunoblotting of RAW 264.7 cells upon Ro41-5253 and LPS treatment. Graphs show the mean ± SEM of duplicate wells and represent three independent experiments. An unpaired t-test was used for statistical analysis (NS, not significant; * p < 0.05, ** p < 0.01). Each panel represents an experiment performed at least three times. IL-1β, -18, interleukin-1β, -18; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; RAR, retinoic acid receptor; TNF-α, tumor necrosis factor-α.
Article Snippet: Protein expression was detected by Western blotting with anti-caspase-11 primary antibody (1:1000) (ab 180673; Abcam), anti-GSDMD primary antibody (1:100) (ab 209845; Abcam), anti-NLRP3 primary antibody (1:1000) (AG-20B-0014; AdipoGen, Basel, Switzerland), anti-ASC primary antibody (1:1000) (sc-22514; Santa Cruz), anti-caspase-1 primary antibody (1:500) (sc-514; Santa Cruz), anti-IL-1β primary antibody (1:1000) (MAB401; R&D systems Inc., Minneapolis, MN, USA), anti-α-tubulin antibody (1:1000) (21255; Cell Signaling), and horseradish peroxidaseconjugated secondary antibody (1:5000–10,000) (R&D systems Inc., Minneapolis, MN, USA).
Techniques: Cell Culture, Western Blot, Cytotoxicity Assay, Enzyme-linked Immunosorbent Assay